Special Issue: Lixisenatide in Parkinson's: A Diabetes Drug to Slow Disease Progression?
Jul 1, 2024
00:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Michele Matarazzo interviews Dr. Olivier Rascol on the results of the clinical trial recently published in the New England Journal of Medicine. Tune in to learn about the mechanisms of action and potential of lixisenatide and other GLP-1 receptor agonists in impacting the progression of Parkinson's disease.
Read the article »
MDS Podcast